Maintenance AVElumab After SECond Line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma

A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer

NCT03575013 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

NCT05327530 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC

NCT07225374 ·Status: RECRUITING ·Phase: PHASE2

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

NCT03617913 ·Status: COMPLETED ·Phase: PHASE2

Single-Dose Intravesical Chemotherapy After Diagnostic URS

NCT05810623 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer

NCT05699135 ·Status: TERMINATED

Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo

NCT03421652 ·Status: COMPLETED ·Phase: PHASE2

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

NCT07421700 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma

NCT03324282 ·Status: TERMINATED ·Phase: PHASE2

Dose Dense MVAC for Muscle Invasive Bladder Cancer

NCT01031420 ·Status: COMPLETED ·Phase: PHASE2

A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer

NCT03498196 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

NCT00028756 ·Status: COMPLETED ·Phase: PHASE3

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

NCT03775265 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma

NCT03390595 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

NCT06774131 ·Status: RECRUITING ·Phase: PHASE3

Avelumab and Radiation in Muscle-Invasive Bladder Cancer

NCT03747419 ·Status: TERMINATED ·Phase: PHASE2

Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma

NCT00461851 ·Status: COMPLETED ·Phase: PHASE2

Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).

NCT05038657 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer

NCT05496192 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi Arabia

NCT06505746 ·Status: COMPLETED

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients

NCT02740426 ·Status: UNKNOWN ·Phase: PHASE2

DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.

NCT06820255 ·Status: RECRUITING ·Phase: PHASE4

SOGUG-AVELUMAB_RWD

NCT05700344 ·Status: COMPLETED

Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

NCT06686381 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

NCT05092958 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3